Splanchnic Nerve Stimulation for Treatment of Obesity

• US 20100234907A1
• Filed: 02/12/2010
• Published: 09/16/2010
• Est. Priority Date: 03/22/2002
• Status: Abandoned Application

• Current Assignee: John D. Dobak III
• Original Assignee: John D. Dobak III
• Inventors: Dobak, John D. III
• Application Number:
  US12/704,815
• Publication Number:
  US 20100234907A1
• Time in Patent Office: Days
• US Class Current: 607/3
• CPC Class Codes: A61N 1/0551 Spinal or peripheral nerve electrodes
• CPC Class Codes: A61N 1/36007 of urogenital or gastrointestinal organs, e.g. for incontinence control
• CPC Class Codes: A61N 1/36085 Eating disorders or obesity
• CPC Class Codes: A61N 1/3616 Voltage density or current density
• CPC Class Codes: A61N 1/36167 Timing, e.g. stimulation onset

Abstract

A method for the treatment of obesity or other disorders by electrical activation or inhibition of the sympathetic nervous system is disclosed. This activation or inhibition can be accomplished by stimulating the greater splanchnic nerve or other portion of the sympathetic nervous system using an electrode. This nerve activation can result in reduced food intake and increased energy expenditure.

Claims

1. A method of treating type II diabetes, comprising:

providing a pulse generator that emits electrical pulses in a programmable stimulation pattern, wherein the stimulation pattern is programmed to treat type II diabetes in the patient from electrical activation of a splanchnic nerve of the patient and wherein the stimulation pattern in further programmed to keep the patient'"'"'s blood pressure within safe limits during the electrical activation of the splanchnic nerve; and

electrically activating the splanchnic nerve of the patient with said pulse generator using said stimulation pattern so as to achieve type II diabetes treatment and keep the patient'"'"'s blood pressure within safe limits.

2. The method according to claim 1, further compromising using a lead/electrode assembly transvasculary.

3. The method according to claim 2, wherein the lead/electrode assembly is within a vessel.

4. The method according to claim 3, wherein the vessel is within an azygous vein.

5. The method according to claim 3, wherein the lead/electrode is expandable.

6. The method recited in claim 1, wherein said activation further comprises activation of the splanchnic nerve to induce weight loss.

7. The method recited in claim 6, wherein said activation of the splanchnic nerve induces weight loss by reducing appetite.

8. The method recited in claim 7, wherein said activation of the splanchnic nerve reduces appetite by reducing plasma gherlin hormone levels.

9. The method recited in claim 6, wherein said activation of the splanchnic nerve induces weight loss by increasing energy expenditure.

10. The method recited in claim 9, wherein said activation of the splanchnic nerve increases energy expenditure by increasing plasma catecholamine levels.

11. The method recited in claim 6, wherein said activation of the splanchnic nerve induces weight loss by normalizing catecholamine levels.

12. The method recited in claim 6, wherein said activation of the splanchnic nerve induces weight loss by inducing satiety.

13. The method recited in claim 1, wherein said activation of the splanchnic nerve reduces gastric motility.

14. The method recited in claim 1, wherein said activation of the splanchnic nerve increases pyloric sphincter tone.

15. The method recited in claim 1, wherein said activation of the splanchnic nerve delays gastric emptying.

16. The method recited in claim 1, wherein the splanchnic nerve is selected from the group consisting of the greater splanchnic nerve, the lesser splanchnic nerve and the least splanchnic nerve.

17. The method recited in claim 1, wherein said activation of the splanchnic nerve reduces insulin secretion.

18. The method recited in claim 1, further compromising electrically stimulating the splanchnic nerve, wherein the splanchnic nerve is inhibited.

19. A method for treating type II diabetes in a patient comprising:

electrically stimulating a splanchnic nerve transvascularly in a mammal; and

electrically activating the splanchnic nerve, wherein the electrically activating is performed in a stimulation pattern for a first time period within a period of about 24 hours and ceasing the electrical activation of the splanchnic nerve for a second time period within the period of about 24 hours, wherein the stimulation pattern includes a stimulation intensity pattern adapted and configured to result in net reduction in fat in the liver over a period of about 4 to 8 weeks.

20. The method of claim 19, further comprising repeating the steps of electrically activating and ceasing the electrical activation.

21. The method of claim 19, wherein the first time period plus the second time period equals about 24 hours.

22. The method of claim 19, further comprising varying the stimulation intensity over time.

23. The method of claim 19, further comprising increasing the stimulation intensity daily.

24. The method of claim 19, further comprising creating a unidirectional action potential in the splanchnic nerve.

25. The method of claim 19, further comprising creating an anodal block in the splanchnic nerve.

26. The method of claim 19, further comprising administering an alpha sympathetic receptor blocker.

27. The method of claim 19, further comprising titrating the electrical activating to the plasma level of a catecholamine achieved during therapy.

28. The method of claim 19, wherein the electrically activating is performed about every three hours, for durations of between about 2 to 30 minutes.

29. The method of claim 19, wherein the electrically activating is delivered at intervals coinciding with meal times.

30. The method of claim 19, wherein the electrically activating lasts from between 1 and 3 hours.

31. The method of claim 19, wherein the electrically activating starts just prior to the meal.

32. The method of claim 19, wherein the electrically activating stimulation intensity is increased in a stepwise manner.

33. The method of claim 19, in which the stimulation pattern includes increasing the stimulation intensity in increments which allow for habituation to the increased intensity.

34. The method of claim 33, in which the stimulation intensity is incremented by about 0.5 mA daily.